Inhalants are a serious public health concern. They are among the most common and pernicious forms of substance use and the least studied of the major drugs. Inhalant use is associated with harmful outcomes that rival or exceed those characteristic of other drugs of abuse. They disproportionately affect vulnerable subpopulations including the poor, select minority groups, the mentally ill, and persons involved with the juvenile and criminal justice systems. Inhalants can lead to """"""""sudden sniffing death"""""""" and serious accidents. Very little research on inhalant use disorders exists, which is also reflected in minimal description of inhalant use disorders in the DSM-IV. Recent findings have raised questions about the reliability and validity of DSM-IV inhalant use disorders, indicating that further research is needed regarding the dimensionality of problematic inhalant use and key signs and symptoms of inhalant use disorders, including tolerance and withdrawal. This information is necessary to inform the development of clinically useful diagnostic and assessment tools, understand the full range of treatment needs of inhalant users, and to develop evidence-based treatments. The importance is elevated in light of the absence of evidenced-based treatments for inhalant use disorders. The proposed research will help address these gaps in knowledge using data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). NESARC is a nationally representative survey of U.S. residents 18 and older and is among the largest (N= 43,093) and most recently completed psychiatric epidemiological studies. This data source contains DSM-IV concordant data on inhalant-related signs/symptoms and disorders, in addition to Axis I and Axis II psychiatric disorders, for one of the largest community based samples of inhalant users. This study will examine the prevalence, associations, and significance of inhalant symptoms;test the latent structure of DSM-IV inhalant use disorders;and examine diagnostic orphans and alternate symptom configurations of inhalant use disorders.
This study examines the signs and symptoms associated with using inhalants. The purpose of this study is to better understand the course of inhalant use disorders, with a long-term goal of improving assessment and treatment.
| Vaughn, Michael G; Fu, Qiang; Perron, Brian E et al. (2012) Risk profiles among adolescent nonmedical opioid users in the United States. Addict Behav 37:974-7 |
| Ahmedani, Brian Kenneth; Perron, Brian; Ilgen, Mark et al. (2012) Suicide thoughts and attempts and psychiatric treatment utilization: informing prevention strategies. Psychiatr Serv 63:186-9 |
| Perron, Brian E; Ahmedani, Brian K; Vaughn, Michael G et al. (2012) Use of Salvia divinorum in a nationally representative sample. Am J Drug Alcohol Abuse 38:108-13 |
| Vaughn, Michael G; Fu, Qiang; Beaver, Kevin M et al. (2011) Effects of childhood adversity on bullying and cruelty to animals in the United States: findings from a national sample. J Interpers Violence 26:3509-25 |
| Ilgen, Mark A; Roeder, Kathryn M; Webster, Linda et al. (2011) Measuring pain medication expectancies in adults treated for substance use disorders. Drug Alcohol Depend 115:51-6 |
| Perron, Brian E; Mowbray, Orion; Bier, Sarah et al. (2011) Service use and treatment barriers among inhalant users. J Psychoactive Drugs 43:69-75 |
| Ilgen, Mark A; Price, Amanda M; Burnett-Zeigler, Inger et al. (2011) Longitudinal predictors of addictions treatment utilization in treatment-naïve adults with alcohol use disorders. Drug Alcohol Depend 113:215-21 |
| Howard, Matthew O; Bowen, Scott E; Garland, Eric L et al. (2011) Inhalant use and inhalant use disorders in the United States. Addict Sci Clin Pract 6:18-31 |
| Perron, Brian E; Glass, Joseph E; Ahmedani, Brian K et al. (2011) The prevalence and clinical significance of inhalant withdrawal symptoms among a national sample. Subst Abuse Rehabil 2011:69-76 |
| Kilbourne, Amy M; Farmer Teh, Carrie; Welsh, Deborah et al. (2010) Implementing composite quality metrics for bipolar disorder: towards a more comprehensive approach to quality measurement. Gen Hosp Psychiatry 32:636-43 |
Showing the most recent 10 out of 14 publications
